Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Angioma

ng-nitroarginine methyl ester has been researched along with Angioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, Y; Guo, ZT; Huang, Q; Li, P; Pan, WK1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Angioma

ArticleYear
Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:8

    Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Chromones; Cinnamates; Cyclin A2; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p21; Endothelial Cells; Hemangioma; Humans; Infant; Infant, Newborn; Morpholines; Neoplasm Invasiveness; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Norepinephrine; Pericytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proliferating Cell Nuclear Antigen; Propranolol; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2015